Skip to main content
Clinical Trials/CTRI/2020/06/025818
CTRI/2020/06/025818Not yet recruiting未知

Efficacy and safety of combination of cholecalciferol and Curcuma longa as an add-on therapy to standard R-CHOP in Diffuse Large Bcell Lymphoma (DLBCL) - a randomized open label 2x2 factorial trial - E-SCHOLAR

JIPMER Intramural fund0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed patients of diffuse large B cell lymphoma (DLBCL) [based on the 2008 World Health Organization classification] to be started on R-CHOP with serum 25 hydroxy D level less than

Exclusion Criteria

  • Subjects previously treated with chemotherapy except for prefix chemotherapy, radiotherapy, immunotherapy or experimental therapies for lymphoma or other malignancy.
  • History of other cancer within the past 5 years except curatively treated non- melanoma skin cancer or in situ carcinoma of
  • uterine cervix.
  • Subjects diagnosed with double hit or triple
  • hit lymphoma.

Investigators

Sponsor
JIPMER Intramural fund

Similar Trials